Steve Schonfeld’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
+160,104
New +$1.51M ﹤0.01% 1476
2026
Q2
– Sell
-15,614
Closed -$173K – 2913
2026
Q1
$173K Sell
15,614
-15,330
-50% -$194K ﹤0.01% 1776
2025
Q4
$513K Buy
+30,944
New +$442K ﹤0.01% 1388
2025
Q3
– Sell
-306,399
Closed -$2.94M – 2484
2025
Q2
$2.94M Buy
+306,399
New +$1.7M 0.02% 794
2024
Q4
– Sell
-208,640
Closed -$3.77M – 2298
2024
Q3
$3.77M Buy
208,640
+40,317
+24% +$563K 0.03% 634
2024
Q2
$1.73M Buy
168,323
+23,623
+16% +$243K 0.01% 967
2024
Q1
$1.54M Buy
144,700
+83,700
+137% +$711K 0.01% 1075
2023
Q4
$557K Buy
61,000
+22,256
+57% +$192K ﹤0.01% 1248
2023
Q3
$402K Buy
+38,744
New +$531K ﹤0.01% 1259

Other funds holding PHAT

Steve Schonfeld's PHAT Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Phathom Pharmaceuticals (PHAT) in Q3 2026: 160,104 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in PHAT as recently as Q1 2026.

Steve Schonfeld first reported a position in PHAT in Q3 2023 and has held it in 9 quarters since. The position peaked at $3.77M in Q3 2024. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • Steve Schonfeld held 160,104 shares of Phathom Pharmaceuticals worth $1.17M as of Q3 2026.
  • Phathom Pharmaceuticals was a new Steve Schonfeld position in Q3 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1476 holding.
  • Steve Schonfeld first reported a position in Phathom Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Steve Schonfeld's Phathom Pharmaceuticals position peaked at $3.77M in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.